Tissue DonorsTransplant Donor SiteLiving DonorsRegistriesHistocompatibility TestingTissue and Organ ProcurementKidney TransplantationBone Marrow TransplantationBone MarrowHLA AntigensBone Marrow CellsGraft SurvivalTransplantation, HomologousDirected Tissue DonationCadaverGraft vs Host DiseaseBlood DonorsHistocompatibilityGraft RejectionImmunosuppressive AgentsHematopoietic Stem Cell TransplantationWaiting ListsUnrelated DonorsTreatment OutcomeTransplantation ConditioningWhole-Body IrradiationRetrospective StudiesTime FactorsAntilymphocyte SerumTransplantsSurvival RateSurvival AnalysisRisk FactorsHeart TransplantationBone Marrow DiseasesHematopoietic Stem CellsBone Marrow ExaminationTransplantationLung TransplantationBone Marrow NeoplasmsTransplantation, AutologousIncidenceImmunosuppressionBone Marrow PurgingFollow-Up StudiesPostoperative ComplicationsHematopoiesisCyclosporineLeukemiaMice, Inbred C57BLAnemia, AplasticTransplantation ImmunologyTacrolimusColony-Forming Units AssayProspective StudiesRecurrenceCytomegalovirus InfectionsCells, CulturedRadiation ChimeraCell DifferentiationHematologic NeoplasmsTissue and Organ HarvestingLiver TransplantationFlow CytometryT-LymphocytesFetal Tissue TransplantationPrognosisCohort StudiesAge FactorsKidney Failure, ChronicLiver FailureAcute DiseaseSpleenUnited StatesBrain DeathTransplantation, IsogeneicRisk AssessmentMycophenolic AcidAntigens, CD34Stromal CellsImmunocompromised HostBiopsyLeukemia, Myeloid, AcuteTransplantation ChimeraTransplantation ToleranceNeoplasmsMice, Inbred BALB CMultivariate AnalysisStem Cell TransplantationCell SeparationPatient SelectionGranulocytesIsoantibodiesPolymerase Chain ReactionMyelodysplastic SyndromesMultiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBusulfanProportional Hazards ModelsLeukocyte Transfusion